These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Current role of image-guided ablative therapies in lung cancer. Simon CJ, Dupuy DE. Expert Rev Anticancer Ther; 2005 Aug; 5(4):657-66. PubMed ID: 16111466 [Abstract] [Full Text] [Related]
7. Thermal ablation in renal cell carcinoma management: a comprehensive review. Wagstaff P, Ingels A, Zondervan P, de la Rosette JJ, Laguna MP. Curr Opin Urol; 2014 Sep; 24(5):474-82. PubMed ID: 25051022 [Abstract] [Full Text] [Related]
16. Radiofrequency and microwave ablation of lung tumors. Abbas G, Pennathur A, Landreneau RJ, Luketich JD. J Surg Oncol; 2009 Dec 15; 100(8):645-50. PubMed ID: 20017162 [Abstract] [Full Text] [Related]
17. Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role? Gardiner RE, Jahangeer S, Forde P, Ariffin AB, Bird B, Soden D, Hinchion J. Cancer Metastasis Rev; 2015 Mar 15; 34(1):129-44. PubMed ID: 25726003 [Abstract] [Full Text] [Related]
18. Radiofrequency ablation: a safe and effective treatment in nonoperative patients with early-stage lung cancer. Healey TT, Dupuy DE. Cancer J; 2011 Mar 15; 17(1):33-7. PubMed ID: 21263265 [Abstract] [Full Text] [Related]
19. The use of PTC and RFA as treatment alternatives with low procedural morbidity in non-small cell lung cancer. Choe YH, Kim SR, Lee KS, Lee KY, Park SJ, Jin GY, Lee YC. Eur J Cancer; 2009 Jul 15; 45(10):1773-9. PubMed ID: 19285385 [Abstract] [Full Text] [Related]